Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesGreen Thumb Industries Inc

Green Thumb Industries Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
6.56 USD -0.14 ( 2.09%)
Last update at 2026-11-04T21:00:00Z
VOLUME
102956
Market Cap
1617.56M
P/E
13.45

Momentum Score

…

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
6.54
Low
6.94
High
52 Week Price Range
5.29
Low
10.43
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Green Thumb Industries is a U.S. multi-state cannabis company that manufactures branded cannabis products and operates retail dispensaries serving medical and adult-use markets. Long-term growth drivers include expansion of legal cannabis markets, scaling retail footprint and brand penetration, and new product rollouts that may benefit from rising consumer demand; the company appears positioned to capture share through an integrated retail-to-manufacturing model. Principal risks include continued federal illegality, state regulatory variability and licensing constraints, competitive pressures from other MSOs and illicit markets, and tax and banking limitations that could pressure margins and access to capital.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
6.70
Dividend Yield
-
Revenue TTM
1209.37M
Revenue Per Share
5.29
Gross Profit TTM
566.88M
Debt / Equity
-
ROE
6.85%
Net Debt
83.27M
ROCE
5.27%
Diluted EPS TTM
0.55

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 263.36M 200.14M 156.05M 108.43M 204.97M
Minority interest -1.90M -0.77M -1.15M -1.68M 4.93M
Net income 114.15M 73.08M 36.27M 11.98M 75.44M
Selling general administrative 437.19M 376.68M 341.86M 294.40M 277.09M
Gross profit 574.89M 601.11M 526.50M 503.96M 491.93M
Reconciled depreciation 197.01M 167.59M 149.02M 140.65M 102.58M
Ebit - - - 210.99M 226.95M
Ebitda - - - 129.63M 329.53M
Non operating income net other - - - - 12.11M
Operating income 137.70M 224.43M 184.63M 209.57M 214.84M
Interest expense 20.02M 24.27M 19.07M 21.20M 21.98M
Tax provision 147.30M 126.29M 118.63M 94.78M 124.61M
Interest income 11.38M 9.07M 6.70M 4.07M 1.43M
Net interest income -8.64M -15.19M -12.38M -17.13M -20.54M
Income tax expense - - - 94.78M 124.61M
Total revenue 1175.30M 1137.14M 1054.55M 1017.38M 893.56M
Total operating expenses 1037.60M 912.72M 869.92M 807.81M 277.09M
Cost of revenue 600.40M 536.03M 528.06M 513.41M 401.63M
Total other income expense net 134.30M -9.09M -16.21M -84.00M 10.68M
Net income from continuing ops 116.05M 73.85M 37.42M 13.65M 80.36M
Net income applicable to common shares - - - 11.98M 75.44M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2790.06M 2537.01M 2490.06M 2433.53M 2385.85M
Intangible assets 436.68M 488.29M 538.68M 589.52M 675.49M
Other current assets 18.40M 14.68M 5.38M 197.23M 246.66M
Total liab 879.41M 747.93M 786.80M 768.10M 766.37M
Total stockholder equity 1905.43M 1789.08M 1703.26M 1664.92M 1621.12M
Deferred long term liab - - - - 81.85M
Other current liab - - - 369.20M 91.24M
Common stock - - - 1663.56M 1619.48M
Capital stock 1780.59M 1758.50M 1703.85M 1663.56M 1633.67M
Retained earnings 165.42M 51.27M -21.82M -58.09M -70.06M
Other liab - - - 97.61M 140.30M
Good will 592.15M 589.69M 589.69M 589.69M 632.85M
Other assets - - - 3.06M 127.88M
Cash 274.30M 171.69M 161.63M 177.68M 230.42M
Total current liabilities 177.31M 164.97M 126.05M 146.57M 204.38M
Net debt - 83.27M 146.89M 96.95M 9.51M
Short term debt - - - 275.67M 0.78M
Short long term debt 18.50M 12.06M 3.00M 1.04M 0.78M
Other stockholder equity - - - 1641.68M 1527.35M
Property plant equipment - - - 557.87M 409.07M
Total current assets 577.17M 403.90M 342.76M 351.35M 364.23M
Long term investments 205.88M 83.88M 89.30M 74.17M 94.90M
Net tangible assets - - - 485.71M 312.78M
Net receivables 51.27M 52.83M 42.98M 38.45M 22.10M
Long term debt 226.40M 242.90M 305.53M 274.63M 239.15M
Inventory 158.29M 147.16M 112.97M 115.67M 95.47M
Accounts payable 24.57M 24.77M 24.50M 123.23M 112.36M
Noncontrolling interest in consolidated entity - - - 0.52M -1.64M
Non currrent assets other 2.10M 2.17M 2.56M 270.93M 209.31M
Non current assets total 2212.89M 2133.11M 2147.30M 2082.18M 2021.62M
Capital lease obligations 273.45M 275.74M 261.76M 249.28M 191.76M
Long term debt total - - - - 239.15M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -75.49M -9.80M -8.30M -5.80M -60.63M
Change to liabilities - - - 0.69M -13.97M
Total cashflows from investing activities - - - -219.95M -280.73M
Net borrowings -10.70M -56.64M 24.42M 19.15M 138.19M
Total cash from financing activities -50.94M -95.59M -13.11M 8.64M 295.34M
Change to operating activities - - - -39.54M -24.04M
Net income 114.15M 73.08M 36.27M 11.98M 75.44M
Change in cash 113.59M 10.05M -16.05M -52.74M 146.66M
Begin period cash flow 171.69M 161.63M 177.68M 230.42M 83.76M
End period cash flow 285.28M 171.69M 161.63M 177.68M 230.42M
Total cash from operating activities 294.93M 195.18M 224.97M 158.56M 132.05M
Issuance of capital stock - - 0.00M 0.00M 155.50M
Depreciation 197.01M 167.59M 149.02M 105.84M 75.69M
Other cashflows from investing activities - - - -34.64M -32.25M
Dividends paid - - - - 11.03M
Change to inventory -12.89M -35.02M 1.12M -19.79M -16.44M
Change to account receivables 1.09M -9.86M -12.00M -9.26M -0.65M
Sale purchase of stock -38.87M -43.08M -39.86M 3.82M 169.76M
Other cashflows from financing activities - - - -14.33M -12.61M
Change to netincome - - - 77.31M 22.92M
Capital expenditures 81.07M 80.19M 220.03M 179.50M 187.85M
Change receivables - - - -9.26M -0.65M
Cash flows other operating - - - -27.99M 29.82M
Cash and cash equivalents changes - - - -52.74M 146.66M
Change in working capital -75.93M -83.47M -35.84M -70.27M -65.27M
Stock based compensation 44.93M 33.31M 28.19M 27.14M 19.60M
Other non cash items -5.74M -12.55M 9.53M -21.42M 6.10M
Free cash flow 213.86M 115.00M 4.93M -20.94M -55.80M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
GTBIF
Green Thumb Industries Inc		 -0.14
2.09%		 6.56 13.45 25.19 1.34 0.86 1.58 3.76
MKKGY
Merck KGaA ADR		 0.85
2.56%		 34.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 2.55
1.52%		 170.00 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.31
1.49%		 21.06 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 40.91 - 10.66 0.01 1.16 2.94 23.11

Profile*

Green Thumb Industries Inc

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

325 West Huron Street, Chicago, IL, United States, 60654

312 471 6720

https://www.gtigrows.com

4900

Name Title Year Born
Mr. Benjamin Kovler Founder, Chairman & CEO 1979
Mr. Anthony Georgiadis CFO & Director 1978
Mr. Mathew Faulkner Chief Accounting Officer 1973
Mr. Swadheen Sehgal Chief Information Officer NA
Mr. Andrew Laurence Grossman EVP of Capital Markets & Investor Relations 1974
Ms. Linda Marsicano VP of Communications 1968
Mr. Daniel Shaker Sr. VP of National Sales 1971
Ms. Kate Denton Sr. VP of Marketing NA
Mr. Bret Kravitz Chief Corp. Counsel 1980
Ms. Dina Rollman Sr. VP of Gov. & Regulatory Affairs 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…